Ads
related to: bristol-myers squibb- Savings Card
See If You Are Eligible To Save
On An ELIQUIS Prescription
- ELIQUIS & Safety Info
See Full Safety Info &
Boxed Warning. Learn More
- Chat With Elise
Get Help From Our
Virtual Assistant, Elise
- ELIQUIS HCP Info
Visit the Official US Healthcare
Website for ELIQUIS Safety Info
- Prescribing Info
See Full Prescribing Info
Including Boxed Warning
- Doctor Discussion Guide
Learn More About The Interactive
Eliquis Doctor Discussion Guide
- Savings Card
Search results
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 3 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Clinical Trials Arena via Yahoo Finance· 2 days agoPrecede Biosciences has announced positive results for its novel liquid biopsy assay, which can...
Dividends Are a Benefit, But Only From Companies That Can Afford to Pay Them | Investing.com
Investing.com· 14 hours agoFew financial topics have been the subject of more articles than dividend investing, and for good...
10 Health Care Stocks Whale Activity In Today's Session - AbbVie (NYSE:ABBV), Bristol-Myers Squibb...
Benzinga· 4 days agoLoading... Loading... This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga ...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 3 days agoProgression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf;...
Allen Institute's cell lines could lead to new drugs for hypertrophic cardiomyopathy
FierceBiotech· 9 hours agoHypertrophic cardiomyopathy, or HCM, is a common but potentially lethal heart disease. While...
GSK blood cancer drug nearly halves risk of death in late-stage trial
AOL· 3 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage ...
A 'robust' earnings outlook is driving further optimism for stocks in 2024
Yahoo Finance via AOL· 7 days agoEarnings estimates for the S&P 500 holding up better than normal is one of the key reasons Wall...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 4 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Novartis leukemia drug more effective than older treatments in trial
Reuters· 5 days ago, opens new tab said patients with a type of leukemia who took its Scemblix had a significantly...
Ad
related to: bristol-myers squibb